Ekso Bionics Holdings Inc at HC Wainwright Investment Conference - New York Transcript
Good afternoon, and thanks for joining us to have a conversation with Scott Davis, President and CEO; and Jerome Wong, CFO of Ekso Bionics. Ekso is developing and commercializing exoskeletons that are used either in neurorehabilitation or increased productivity and reduced injury in sectors such as construction that require repeated action.
Management recently acquired exoskeletons from Parker Hannifin to discuss their products and their current and expected commercial growth. Let's get started with Scott and Jerome.
So thank you for joining us today and taking our invitation to talk to our audience today.
You bet.
Questions & Answers
So Scott, for starters, help us understand what are exoskeletons and how are they being used in inpatient rehabilitation these days?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
